When an author submits a manuscript to Preventing Chronic Disease (PCD), the journal’s editors evaluate it for overall quality and appropriateness for the journal’s readership. Once cleared at this level, the manuscript undergoes confidential peer review.
The solicitation of a manuscript by PCD editors or others engaged on PCD’s behalf (like a guest editor) will not guarantee that the article can be accepted for publication. The journal’s editor in chief makes final publication selections. Editorial employees members edit accepted papers for organization, grammar, style, format, and clarity before publication. Authors may supply suggestions on these edits however do not have right of refusal.
We tend to are committed to evaluating and publishing papers promptly and to upholding the highest standards of ethical conduct. Papers that categorical novel ideas of interest to a broad public health audience receive priority.
Overlapping or duplicate publication
Adapted from “Overlapping Publications” in Uniform Requirements for Manuscripts Submitted to Biomedical JournalsExternal Web Site Icon, created by the International Committee of Medical Journal Editors (ICMJE, or Vancouver Group).
PCD could be a primary-supply periodical. We tend to can not take into account manuscripts that are simultaneously being thought of by alternative journals, and we have a tendency to require authors to comply with an authorship statement that verifies that PCD is the only journal to which the authors have submitted their manuscript. Among the principal issues that have led to the present policy are: 1) the potential for disagreement when two (or more) journals claim the proper to publish a manuscript that has been submitted simultaneously to additional than one; and 2) the likelihood that two or a lot of journals will unknowingly and unnecessarily undertake the work of peer review, edit the identical manuscript, and publish the same article.
However, PCD might attempt to simultaneously or jointly publish a commentary if the editors believe that doing thus would be in the best interest of public health.
Redundant (or duplicate) publication is publication of a paper that overlaps substantially with one already printed in print or electronic media.
Readers of primary-supply periodicals, whether print or electronic, need to be in a position to trust that what they’re reading is original unless there is a clear statement that the author and editor are intentionally republishing an article. The bases of this position are international copyright laws, moral conduct, and cost-effective use of resources. Duplicate publication of original research is particularly problematic, since it will end in inadvertent double counting or inappropriate weighting of the results of one study, which distorts the accessible proof.
The editors of PCD don’t want to receive papers on work that has already been reported in massive half in an exceedingly printed article or is contained in another paper that has been submitted or accepted for publication elsewhere, in print or in electronic media. This policy will not preclude the journal considering a paper that has been rejected by another journal, or an entire report that follows publication of a preliminary report, such as an abstract or poster displayed at a professional meeting. PCD does not take into account results posted in clinical trial registries as previous publication if the results are presented within the registry in the form of a brief structured abstract or table. The Results registry should either cite the total publication or embody a press release that indicates that the report has not been printed in a very peer-reviewed journal.
When submitting a paper, the author must build an entire statement to the editor regarding all submissions and former reports (including meeting shows and posting of leads to registries) that might be considered redundant or duplicate publication. The author must alert the editor if the manuscript includes subjects regarding that the authors have printed a previous report or have submitted a connected report to another publication. Any such report must be mentioned and referenced in the new paper. Copies of such material should be included with the submitted manuscript to help the editor decide a way to handle the matter.
If redundant or duplicate publication is attempted or occurs without such notification, authors ought to expect editorial action to be taken. At the smallest amount, prompt rejection of the submitted manuscript ought to be expected. If the editor wasn’t responsive to the violations and therefore the article has already been revealed, then a notice of redundant or duplicate publication can in all probability be published with or without the author’s clarification or approval. See Responding to Allegations of Attainable Misconduct below.
Preliminary reporting to public media, governmental agencies, or makers of scientific data described in an exceedingly paper or a letter to the editor that has been accepted however not nonetheless revealed violates the policy of PCD. See News Media Inquiries below.
Acceptable Secondary Publication
Certain sorts of articles, like guidelines made by governmental agencies and skilled organizations, may would like to reach the widest attainable audience. In such instances, PCD editors might deliberately publish material that is additionally being published in different journals, with the agreement of the authors and therefore the editors of those journals. Secondary publication for varied other reasons, in the identical or another language, especially in different countries, is justifiable and will be beneficial only if the following conditions are met.
The authors have received approval from the editors of both journals; the editor concerned with secondary publication should have a photocopy, reprint, or manuscript of the primary version.
The priority of the first publication is respected is specifically negotiated by each editors.
The paper for secondary publication is intended for a completely different cluster of readers; an abbreviated version could be sufficient.
The secondary version faithfully reflects the data and interpretations of the first version.
The footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been revealed in whole or in part and states the primary reference. A appropriate footnote may scan: “This article is based on a study first reported in the [title of journal, with full reference].” Permission for such secondary publication ought to be free of charge.
The title of the secondary publication ought to indicate that it is a secondary publication (complete republication, abridged republication, complete translation, or abridged translation) of a primary publication. Of note, the NLM does not take into account translations to be “republications” and will not cite or index translations when the first article was published in a journal that is indexed in MEDLINE.
Editors of journals that simultaneously publish in multiple languages ought to understand that NLM indexes the first language version. When the full text of an article seems in additional than one language in a journal issue (such as Canadian journals with the article in each English and French), each languages are indicated within the MEDLINE citation.
Update:The most popular supplements category certainly are the thermogenics, in the 90s these supplements accounted for 70% of sales in the US market the manufacturer Nutrex currently has remained as the leader with its line lipo 6 black which promote rapid results in energy and weight loss.